Skip to main content
. 2015 Nov 9;6(42):44995–45004. doi: 10.18632/oncotarget.5707

Table 4. Univariable and multivariable survival analysis by age group.

Patients <70 years old Patients ≥70 years old
Univariable Multivariable Univariable Multivariable
HR (95%CI) p-value HR (95%CI) p-value HR (95%CI) p-value HR (95%CI) p-value
Gender, Female 1.01 (0.89–1.32) 0.41 0.95 (0.74–1.23) 0.72
Site, Gallbladder 1.37 (1.12–1.68) 0.003 1.10 (0.97–1.48) 0.10 1.03 (0.79–1.34) 0.81
CCI 0.96 (0.88–1.05) 0.36 0.98 (0.92–1.05) 0.62
Stage I / Stage II 0.34 (0.29–0.43) < .0001 0.55 (0.42–0.71) < .0001 0.40 (0.30–0.53) < .0001 0.39 (0.29–0.54) < .0001
ECOG, ≥2 2.90 (2.00–4.22) < .0001 2.45 (1.67–3.59) < .0001 2.78 (2.03–3.81) < .0001 2.05 (1.48–3.84) < .0001
Treatment < .0001
Surgery 0.16 (0.13–0.21) < .0001 0.20 (0.15–0.27) < .0001 0.27 (0.20–0.37) < .0001 0.29 (0.21–0.41) < .0001
Palliative chemotherapy 0.49 (0.39–0.62) < .0001 0.44 (0.34–0.56) < .0001 0.72 (0.53–0.99) 0.04 0.50 (0.36–0.71) < .0001
Best supportive care

Abbreviations: ECOG PS: European Cooperative Oncology Group Performance Status; CCI: Charlson Co-morbidity index